Effects of home confinement during COVID-19 outbreak on glycemic control in patients with type 2 diabetes receiving telemedicine support

Acta Diabetol. 2022 Feb;59(2):281-284. doi: 10.1007/s00592-021-01817-4. Epub 2021 Nov 12.

Authors

Daniele Scoccimarro^{1

2}, Gianluca Giove^{3

4}, Antonio Silverii^{3

4}, Ilaria Dicembrini^{3

4}, Edoardo Mannucci^{3

4}

Affiliations

¹ University of Florence, Florence, Italy. daniele.scoccimarro@unifi.it.
² Department of Diabetology, Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50134, Florence, Italy. daniele.scoccimarro@unifi.it.
³ University of Florence, Florence, Italy.
⁴ Department of Diabetology, Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50134, Florence, Italy.

No abstract available

Keywords: Body weight; HbA1c; Lockdown; Telemedicine; Type 2 diabetes.

MeSH terms

Blood Glucose
Blood Glucose Self-Monitoring
COVID-19*
Diabetes Mellitus, Type 2* / drug therapy
Diabetes Mellitus, Type 2* / epidemiology
Disease Outbreaks
Glycemic Control
Humans
SARS-CoV-2
Telemedicine*

Substances

Blood Glucose